000 01426 a2200421 4500
005 20250517094820.0
264 0 _c20180327
008 201803s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/srep26191
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCole, Alexander J
245 0 0 _aAssessing mutant p53 in primary high-grade serous ovarian cancer using immunohistochemistry and massively parallel sequencing.
_h[electronic resource]
260 _bScientific reports
_c05 2016
300 _a26191 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCell Line, Tumor
650 0 4 _aFemale
650 0 4 _aGene Expression Profiling
650 0 4 _aHigh-Throughput Nucleotide Sequencing
650 0 4 _aHumans
650 0 4 _aImmunohistochemistry
650 0 4 _aMutation
650 0 4 _aOvarian Neoplasms
_xgenetics
650 0 4 _aTumor Suppressor Protein p53
_xanalysis
700 1 _aDwight, Trisha
700 1 _aGill, Anthony J
700 1 _aDickson, Kristie-Ann
700 1 _aZhu, Ying
700 1 _aClarkson, Adele
700 1 _aGard, Gregory B
700 1 _aMaidens, Jayne
700 1 _aValmadre, Susan
700 1 _aClifton-Bligh, Roderick
700 1 _aMarsh, Deborah J
773 0 _tScientific reports
_gvol. 6
_gp. 26191
856 4 0 _uhttps://doi.org/10.1038/srep26191
_zAvailable from publisher's website
999 _c26029493
_d26029493